The objectives of this funding opportunity as outlined on the CIHR site are as follows:

"The overarching objective of IYS-Net is to improve mental health services and outcomes for youth and their caregivers/families. This will be done by supporting pan-Canadian research, data and knowledge sharing across the IYS networks, thus enabling evidence-informed decision making that integrates research into practice and policy and strengthens each independent Learning Health System (LHS) network.

The specific objectives of Phase 1 are to:

• Continue to build and strengthen research and knowledge mobilization capacity within and across IYS networks, including among researchers, service providers, decision makers, and policy makers.
• Catalyze collaborations and knowledge sharing within and across IYS networks that will contribute evidence about best and wise practices regarding the development, implementation, policies, effectiveness, and ongoing monitoring of IYS in Canada, and using diverse research methods such as those based in Indigenous ways of knowing and engagement of youth and caregivers/families.
• Support the uptake of common data approaches and open science practices within and across IYS networks to support LHS networks, and to identify best and wise practices for LHSs in community-based settings.
• Facilitate effective and meaningful youth and caregiver/family engagement throughout all stages of the project, ensuring youth and caregivers/families, as well as providers and policy makers, all play key roles."

The mission of the FY23 Peer Reviewed Cancer Research Program (PCRP) is to support research leading to the elimination of death/suffering from prostate cancer and as well as to enhance the well-being of Service Members, Veterans, and their families experiencing the impact of prostate cancer.  Within this context, the PCRP supports research that addresses specific gaps in prostate cancer research and clinical care.

Exploration – Hypothesis Development Award – Letter of Intent due June 22, 2023

A pre-application must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  

Please contact Jill Sherman at intl.research@lakeheadu.ca.

 The FY23 PRCRP funding opportunity announcements for the following award mechanisms are posted on the Grants.gov website. 

 The FY23 PRCRP appropriation will provide funds for research into cancers that are not addressed in the other CDMRP cancer programs (https://cdmrp.army.mil/researchprograms).  To be considered for funding, applications for the FY23 PRCRP must address at least one of the FY23 PRCRP Topic Areas: 

The FY23 PRCRP Topic Areas:

Funding Opportunities-FY23 PRCRP, Congressionally Directed Medical Research Programs (CDMRP), US DoD (health.mil)

Advancing Clinical Care Through Clinical Trials Award – Preproposal due May 25, 2023

Idea Award – Preproposal due May 25, 2023

Impact Award – Preproposal due May 25, 2023

Pre-applications are required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  

For more information, please contact Jill Sherman at intl.research@lakeheadu.ca.

The FY23 PRCRP appropriation will provides funds for research into cancers not addressed in the other CDMRP cancer programs: (https://cdmrp.army.mil/researchprograms).  To be considered for funding, applications for the FY23 PRCRP must address at least one of the FY23 PRCRP Topic Areas:

Funding Opportunities-FY23 PRCRP, Congressionally Directed Medical Research Programs (CDMRP), US DoD (health.mil)

Patient Well-Being and Survivorship Award – Letter of Intent due July 25, 2023

Career Development Award – Fellow Option – Letter of Intent due July 25, 2023

Career Development Award – Resident Option – Letter of Intent due July 25, 2023

Translational Team Science Award – Letter of Intent due July 25, 2023

Pre-applications are required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.

 Please contact Jill Sherman at intl.research@lakeheadu.ca for more information.

The following US Department of Defence funding opportunities support innovative, high-impact research in the area of tick-borne disease.

The following FY23 TBDRP funding opportunity announcements for the following award mechanisms are posted on the Grants.gov website.

• Prevention (Idea Development Award only)

• Pathogenesis (Idea Development Award only)

• Treatment (Therapeutic/Diagnostic Research Award only)

• Diagnosis (Therapeutic/Diagnostic Research Award only)

https://cdmrp.health.mil/funding/tbdrp

Idea Development Award (IDA) – Preproposal due May 25, 2023

Therapeutic/ Diagnostic Research Award (TDRA) – Preproposal due May 25, 2023

For more information, please contact Jill Sherman at intl.research@lakeheadu.ca.

From the OICR website:

"The Cancer Therapeutics Innovation Pipeline (CTIP) Program was established to capitalize on Ontario’s expertise in cancer biology and drug discovery to create a pipeline of validated cancer targets and first-in-class or best-in-class, novel, selective lead molecules (small molecules or biologics) to attract partnerships and/or investment for further preclinical and clinical development. To generate a sustainable pipeline, CTIP will support projects that aim to provide increasing evidence of target validation and disease association using data from knowledgebases, functional assays, and drug screening in relevant in vitro and in vivo models of the cancer type of interest.

Early Validation projects: Deliver robust translational evidence that a Target-of-Interest (TOI) is associated to a specific cancer type based on data from knowledge bases and from studies demonstrating that perturbation of the TOI in relevant cell-based or higher order models produces anti-cancer effects sufficient to trigger a drug discovery campaign.

Funding available: Up to $150,000 per year for a maximum of two years.

Early Accelerator projects: Deliver a validated primary assay to enable initial screening of molecules against a defined target. Preliminary evidence of linearity of results between the primary assay and supporting secondary assays under development is also required.

Funding available: Up to $150,000 for a maximum of one year.

Late Accelerator projects: Deliver confirmed Hit molecules against a defined target using validated primary, secondary and orthogonal assays for screening.

Funding available: Up to $500,000 per year for a maximum of two years.

OICR invites applications from investigators at Ontario academic centres, hospital research institutes, or other government research institutions. CTIP funding is only tenable in Ontario. For-profit entities are not eligible to apply."

• a. Advanced Research Workshops (ARW)
• b. Advanced Training Courses (ATC)
• c. Advanced Study Institutes (ASI)"

For more information, please contact Jill Sherman at intl.research@lakeheadu.ca.

From the CIHR Website:

"The CIHR Institute of Circulatory and Respiratory Health (CIHR-ICRH) and the Canadian Cardiovascular Society (CCS) have established an annual Distinguished Lecturer Award in Cardiovascular Sciences in recognition of an individual's outstanding contribution to the advancement of cardiovascular sciences both in Canada and internationally. The award will be presented to the selected candidate at Vascular 2023, where the recipient will be invited to participate in a session as a part of the Vascular 2023. Vascular 2023 is a world-class event that incorporates separate concurrent annual conferences (congresses/meetings) from the seven host organizations under one roof.

The selected candidate will be an outstanding scientist who has conducted the majority of their research in Canada and who has contributed to the advancement of cardiovascular sciences. The individual may have conducted work in any one of a number of cardiovascular disciplines and within any of the four CIHR research theme areas: biomedical; clinical; health systems and services; and, social, cultural, environmental and population health. The nominated candidate's research should also be in a field of interest to the CIHR-ICRH, CCS, and attendees of Vascular 2023."

If you are interested in being nominated for this award, please contact Dr. Batia Stolar, Associate Vice-President, Research and Graduate Studies, at  bstolar@lakeheadu.ca.

The Forest Sector Investment and Innovation Program (FSIIP) provides funding for strategic investments in the forest sector that:

• improve productivity and innovation
• enhance competitiveness
• support new market access
• provide benefits to Ontario’s broader forest sector
• strengthen regional economies

Support is available under two project categories – business projects and collaboration projects.